Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,314 public trials 326 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Recruiting

Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

NCT07220785

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Generalized Lipodystrophy, Genetic Diseases, Inborn, +12 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
  • Assistance Publique-Hopitaux de Paris (AP-HP) Paris, France
  • Hopital Universitaire Robert-Debre Paris, France
View Trial Details
Recruiting

Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

NCT07223658

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Research Site 7 Charlestown, New South Wales, Australia
  • Research Site 5 Morayfield, Queensland, Australia
  • Research Site 8 East Melbourne, Victoria, Australia
  • Research Site 4 Melbourne, Victoria, Australia
View all 17 locations
View Trial Details
Recruiting

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

NCT06909565

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +13 more
Locations
  • Advanced Cardiovascular LLC Alexander City, Alabama, United States
  • Cardiology, PC Birmingham, Alabama, United States
  • Heart Center Research, LLC Huntsville, Alabama, United States
  • Cardiology Associates Research Group Jonesboro, Arkansas, United States
View all 133 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

NCT07082725

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations
  • UCSF Children's Hospital and Research Center at Oakland Oakland, California, United States
  • University of Minnesota Medical School Minneapolis, Minnesota, United States
  • Mayo Clinic Children's Center - PIN Rochester, Minnesota, United States
  • Children's Medical Center Dallas Dallas, Texas, United States
View all 34 locations
View Trial Details

Related conditions